Nonclinical safety assessment of engineered T cell therapies
Author:
Publisher
Elsevier BV
Subject
Toxicology,General Medicine
Reference56 articles.
1. CAR models: next-generation CAR modifications for enhanced T-cell function;Abate-Daga;Mol. Ther. Oncolytics,2016
2. The clinical potential of gene editing as a tool to engineer cell-based therapeutics;Ashmore-Harris;Clin. Transl. Med.,2020
3. Killing mechanisms of chimeric antigen receptor (CAR) T cells;Benmebarek;Int. J. Mol. Sci.,2019
4. Safety of targeting ROR1 in primates with chimeric antigen receptor-modified T cells;Berger;Cancer Immunol. Res.,2015
5. In vivo tracking of T cells in humans unveils decade-long survival and activity of genetically modified T memory stem cells;Biasco;Sci. Transl. Med.,2015
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Manufacturing CD20/CD19-targeted iCasp9 regulatable CAR-TSCM cells using a Quantum pBac-based CAR-T engineering system;PLOS ONE;2024-08-27
2. A roadmap towards a human-centric safety assessment of advanced therapy medicinal products;Regulatory Toxicology and Pharmacology;2024-06
3. EMA commentary on the guideline on quality, nonclinical and clinical aspects of medicinal products containing genetically modified cells;British Journal of Clinical Pharmacology;2024-04-02
4. Safety Pharmacology in the Era of Precision Medicine;Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays;2024
5. The screening, identification, design and clinical application of tumor-specific neoantigens for TCR-T cells;Molecular Cancer;2023-08-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3